FindTrial
Sign In

A study for recurrence factors in patients with central nervous system solitary fibroma / hemangiopericytoma

A study for recurrence factors in patients with central nervous system solitary fibroma / hemangiopericytoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029718
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-02-10
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solitary Fibrous Tumor / Hemangiopericytoma

Interventions

Case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From Jan. 2009 to June 2019, Primary and retreated Patients who were diagnosed with CNS SPF/HPC by pathologist and treated with operation in West China Hospital, Sichuan University were selected in this study.

Exclusion criteria

Exclusion criteria: 1. Without complete medical records or loss to follow-up; 2. Dying from other diseases; 3. Denying to take part in the study;

Design outcomes

Primary

MeasureTime frame
Time of recurrence/metastasis;Progression-free surviva;—

Secondary

MeasureTime frame
EQ-5D scores;—

Countries

China

Contacts

Public ContactYu Yang

West China Hospital, Sichuan University

yuyang617@hotmail.com+86 17796408016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026